P206 How is the efficacy of patient selection criteria for adjuvant pembrolizumab after curative surgical treatment of clear cell renal cell carcinoma with intermediate to high ris... von Erdem, S., Tantekin, A., Ozervarli, F., Ergul, R., Pazir, Y., Hurdogan, O., Ozluk, Y., Sanli, O., Ozcan, F.

Volltext